Community Practice Connections™: Modifying the Course of Sickle Cell Disease With Modern Interventions

Target Audience
The target audience for this activity is hematologists, specialty nurse practitioners, physician assistants, and registered nurses who treat patients with sickle cell disease. Other health care professionals interested in the treatment of sickle cell disease are also invited to participate.

Program Overview
Sickle cell disease consists of a group of rare genetic blood disorders which are responsible for serious life-threatening complications. In the past several years, a greater understanding of the pathogenesis of these subtypes has led to a number of new and emerging agents that have revolutionized the treatment for these malignancies.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a live satellite symposium presented at the 63rd American Society of Hematology (ASH) Annual Meeting held in December 2021. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with sickle cell disease, putting recent trial data into clinical context. The program is designed both for those who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the impact of poorly managed sickle cell disease on patient outcomes
Evaluate the role of disease-modifying therapies in the management of patients with sickle cell disease
Describe the effects of health inequities on the management of complications of sickle cell disease
Select personalized treatment strategies to reduce complications associated with sickle cell disease